Overexpression of FOXO3a inhibits the proliferation, tumorigenic potential, and invasiveness of HCC cells, while silencing of FOXO3a markedly attenuates protection against tumorigenesis (21, 138). The gene discussed is FOXO3; the disease is hepatocellular carcinoma.